Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

209 results about "Healthy control" patented technology

Managing parameters effecting the comprehensive health of a user

Current health parameters for a user are monitored at a personal health monitoring system. Current health parameters include multiple monitored physical parameters and multiple monitored environmental parameters. The current health parameters are compared with health allowances for the user. A control signal for transmission to a health control device that controls at least one parameter from among the multiple physical parameters and multiple environmental parameters is determined in response to determining that at least one of the current health parameters exceeds at least one of the health allowances, such that the at least one current health parameter that exceeds the at least one of the health allowances is adjusted by the health control device according to the control signal in order to balance the comprehensive health of the user.
Owner:UNILOC 2017 LLC

Biometrics System, Biologic Information Storage, and Portable Device

In a biometrics system for a building entrance unlocking or a bank account authentication, reference information registered under administration by the system is transmitted to a room or mobile-phone for private storage, with the original reference information deleted from the system. Biologic information gotten upon authentication is transmitted through wireless system to the room or mobile-phone for comparison with the reference, the result being returned to the system. Or, the reference is tentatively sent back to the system for comparison with the gotten biologic information. The biologic information sent to mobile-phone also includes health control information for storage and display. Mobile-phone also can receive blood pressure information at a waiting lounge of medical institution though wireless local communication even if the main power shut down. The communication between the biometrics system and the mobile-phone is encrypted. The system includes sensor unit and protection unit, the abnormality thereof being separately checked.
Owner:NL GIKEN

miRNA IN THE DIAGNOSIS OF OVARIAN CANCER

The present invention provides novel methods for diagnosing a state of health based on the determination of specific miRNAs that have altered expression levels in different conditions, e.g. disease states compared to healthy controls.
Owner:HUMMINGBIRD DIAGNOSTICS GMBH

Method and apparatus for monitoring tool performance

A method and system for monitoring tool performance for processing tools in a semiconductor processing system. The semiconductor processing system includes a number of processing tools, a number of processing modules, a number of sensors, and an alarm management system. A tool health control strategy is executed in which tool health data for the processing tool is collected. A tool health analysis strategy is executed in which the tool health data is analyzed. An intervention manager can pause the processing tool when an alarm has occurred. The intervention manager refrains from pausing the processing tool when an alarm has not occurred.
Owner:TOKYO ELECTRON LTD

Localized two-dimensional shift correlated MR spectroscopy of human brain

A two-dimensional (2D) chemical shift correlated MR spectroscopic (COSY) sequence integrated into a new volume localization technique (90°-180°-90°) for whole body MR Spectroscopy. Using the product operator formalism, a theoretical calculation of the volume localization as well as the coherence transfer efficiencies in 2D MRS is presented. A combination of different MRI transmit / receive rf coils is used. The cross peak intensities excited by the proposed 2D sequence are asymmetric with respect to the diagonal peaks. Localized COSY spectra of cerebral frontal and occipital gray / white matter regions in fifteen healthy controls are presented.
Owner:RGT UNIV OF CALIFORNIA

Intelligent air conditioning system

The application of the invention discloses an intelligent air conditioning system. The intelligent air conditioning system comprises a human body health state monitoring device, an indoor environmental monitoring device, a health controlling device and an air conditioner controller; the input end of the air conditioner controller is connected with the human body health state monitoring device and the indoor environmental monitoring device, and the output end of the air conditioner controller is connected with the health controller; the air conditioner controller is used for acquiring human body health indicator information and indoor environmental information in real time, finding information data which cannot meet requirements by judging and analyzing all information data, and controlling actuators corresponding to the information data which cannot meet the requirements to perform corresponding adjusting operations. As can be seen, the intelligent air conditioning system can adjust a condition by combining indoor environment and a human body health state; compared with the prior art that only indoor environment is taken into consideration during adjusting, the intelligence level of an intelligent air conditioner is improved greatly, so that the real intelligent health experience is brought to a user.
Owner:GREE ELECTRIC APPLIANCES INC

Enhanced diagnostic multimarker serological profiling

The present invention is related to methods of early diagnosis of ovarian cancer in a patient by determining serum levels of blood markers using a novel LabMAP™ technology (Luminex Corp., Austin, Tex.), which allows for simultaneous measurement of the blood markers in serum. The panel of blood markers offers extremely high predictive power for discrimination of ovarian cancer from both healthy control patients and from patients with benign pelvic / ovarian tumors. The methods of the present invention allow for rapid, early diagnosis of ovarian cancer with extremely high sensitivity and specificity to be clinically useful in disease diagnosis.
Owner:UNIVERSITY OF PITTSBURGH

Vital signs detection system, vital signs detection method, vital signs processing apparatus, and health control method

A vital signs detection system has a terminal capable of being connected to detecting means of detecting vital signs; a program server of storing a program and / or data to operate the detecting means; and an information server of communicating with the terminal; wherein: when an operation switch of the detecting means is turned ON, the terminal transmits information including the type of the detecting means to the program server; on receiving the information, the program server transmits a predetermined program and / or data corresponding to the information to the terminal according to the information; the detecting means operates according to the predetermined program and / or data received by the terminal, and thereby detects vital signs; and the terminal transmits the vital signs detected by the detecting means to the information server.
Owner:PANASONIC CORP

Methods for diagnosing severe systemic lupus erythematosus

The invention relates to methods and materials involved in diagnosing SLE. More particularly, the invention relates to methods and materials involved in diagnosing SLE, diagnosing severe SLE, and assessing a mammal's susceptibility to develop severe SLE. For example, the invention provides nucleic acid arrays that can be used to diagnose SLE in a mammal. Such arrays can allow clinicians to diagnose SLE based on a simultaneous determination of the expression levels of many genes that are differentially expressed in SLE patients as compared to healthy controls.
Owner:RGT UNIV OF MINNESOTA +1

Method and Apparatus For Health Control

InactiveUS20080162181A1Large user baseReduced rigorousnessFinanceDrug and medicationsThird partyHealth states
A method of health care financing, comprising: calculating an economic burden on an entity caused by a health situation; providing, by a third party, application and monitoring of a health plan for at least 10,000 individuals in least part of the entity; and paying to the third party in response to a proof that said burden is reduced.
Owner:TYLERTON INT INC

Protein characteristic spectrum of active tuberculosis in children and method for creating protein characteristic spectrum

The invention discloses a protein characteristic spectrum of active tuberculosis in children and a method for creating the protein characteristic spectrum. The protein characteristic spectrum of the active tuberculosis in the children is obtained by comparing proteomics difference of an active tuberculosis group and a healthy control group. In addition, the invention further relates to the method for creating the protein characteristic spectrum of the active tuberculosis in the children, protein in blood plasma can be effectively identified and relatively quantified by utilizing a non-marked tandem mass spectrum technology of relative and absolute quantification, and a protein expression difference mass spectrum in the blood plasma of a patient suffering from the active tuberculosis in the children can be obtained by adopting the technology. A series of discovered proteins provide a foundation and resources for searching new more ideal markers; compared with a conventional blood plasma detection method, the method has relatively high sensitivity and specificity, and can be used for screening drugs for the active tuberculosis in the children; at the same time, a new way is provided for a mechanism for exploring occurrence and development of diseases.
Owner:BEIJING CHILDRENS HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV

Psychological pressure assessment method and apparatus

InactiveCN106934199ARealize graded quantitative evaluationHealth-index calculationSensorsQuantitative assessmentStatistical model
The invention is suitable for the technical field of health control and provides a psychological pressure assessment method and apparatus. The method comprises the steps of collecting sample data, and constructing a feature data matrix, wherein the sample data specifically comprises physiological feature data, psychological feature data such as stress scale and the like, basic information of an individual and the like; performing preliminary assessment on the physiological feature data and the psychological feature data by a fuzzy C-mean algorithm and an ordered weighted arithmetic mean operator to obtain respective classification identification results; performing secondary classification whether the results are benign or not for the classification identification results in which psychological pressure exists according to a decision layer fusion model, and outputting secondary classification results in which the psychological pressure exists; and taking the secondary classification results as statistical model inputs, and obtaining a quantized value of the psychological pressure of the individual according to a pressure system theory model-based Cylinder pressure quantization function. According to the method and the apparatus, graded quantitative assessment of the psychological pressure is realized.
Owner:SHENZHEN INST OF ADVANCED TECH

Serum protein marker group for diagnosing MODY (maturity-onset-diabetes of the young) and application thereof

The invention relates to a serum protein marker group for diagnosing MODY (maturity-onset-diabetes of the young) and application thereof. The serum protein marker group comprises five proteins: apolipoprotein C-IV (APOC4), apolipoprotein a (LPA), a complement component C6 (C6), a blood coagulation factor v (F5) and thyroid binding globulin (SERPINA7). ITRAQ (isobaric tags for relative and absolute quantitation) are used to combine with an MALDI-TOF / MS technology to detect; mass spectrum detection shows that expression levels of the serum apolipoprotein C-IV, the apolipoprotein a, the complement component C6 and the blood coagulation factor v protein in serum of a MODY patient are obviously improved, and an expression level of the thyroid binding globulin in the serum of the MODY patient is obviously reduced. Mass spectrum MRM (multiple-reaction-monitoring) also verifies that the five proteins are abnormal in expression in serums of the MODY patient, type-1 and type-2 diabetics and a healthy control group, and are specific proteins.
Owner:XINJIANG MEDICAL UNIV

MicroRNA standardization reference gene and application thereof

The invention relates to a microRNA standardization reference gene and an application thereof. Specifically, with Solexa sequencing, real-time fluorescence quantitative PCR detection, literature screening, statistical analysis methods, the invention carries out researches upon a large amount of samples collected from a healthy control group and different disease patients. As a result, microRNAs let-7d, let-7g, let-7i, or combinations thereof can serve as microRNA standardization housekeeping gene. Compared with reference genes (such as U6, RNU44, RNU48 and miR-16, and the like) most commonly used in current microRNA quantification, the microRNA standardization reference gene has high stability and accuracy.
Owner:MICROMEDMARK BIOTECH CO LTD

Vital signs detection system, vital signs detection method, vital signs processing apparatus, and health control method

A vital signs detection system has a terminal capable of being connected to detecting means of detecting vital signs; a program server of storing a program and / or data to operate the detecting means; and an information server of communicating with the terminal; wherein: when an operation switch of the detecting means is turned ON, the terminal transmits information including the type of the detecting means to the program server; on receiving the information, the program server transmits a predetermined program and / or data corresponding to the information to the terminal according to the information; the detecting means operates according to the predetermined program and / or data received by the terminal, and thereby detects vital signs; and the terminal transmits the vital signs detected by the detecting means to the information server.
Owner:MORI YASUHIRO

Systemic lupus erythematosus

This document relates to methods and materials involved in diagnosing SLE. For example, this document relates to methods and materials involved in diagnosing SLE, diagnosing severe SLE, and assessing a mammal's susceptibility to develop severe SLE. For example, this document provides nucleic acid arrays that can be used to diagnose SLE in a mammal. Such arrays can allow clinicians to diagnose SLE based on a simultaneous determination of the expression levels of many genes that are differentially expressed in SLE patients as compared to healthy controls. In addition, methods and materials for assessing SLE activity, determining the likelihood of experiencing active SLE, and detecting SLE treatment effectiveness are provided herein.
Owner:THE FEINSTEIN INST FOR MEDICAL RES +1

Method for humanbody health assessment anddiseasediagnosis based on human body flora interaction network analysis

ActiveCN108078540AEffective reference indexDiagnostic recording/measuringSensorsNODALHuman body
The invention mainly aims at humanbody health assessment and personalized diagnosis of microbial flora relateddiseases, and proposes and validates an assessment and diagnosis method based on human body flora interaction network analysis. The method aims to detect the number of 15 kinds of special function nodes-containing triangle motifs (trios) in a flora interaction network, wherein there are two major categories including a branch with no special function nodes and a branch with function nodes, the branch with no special function nodes is divided in six typesaccording to positive and negative relations between three nodes, and the branch with the function nodes is divided in nine typesaccording to the number of interaction and positive and negative relations of the function nodes and the triangle motifs. The inventor finds that there is significant difference in the number of specific trios in the flora interaction network between experimental group/disease group and healthy controls by analyzing microbial flora data of six human body parts includingintestines, vaginas, lungs, mouths, semenand skin. The method provides an effective reference index forrisk assessment of humanbodyhealth and disease occurrence, and provides reliable technical support for the personalized diagnosis of the microbial flora relateddiseases.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Aeronautic health control system

The invention discloses an aeronautic health control system, which comprises a master control board, a digital board, an analogue board, a vibration board, a cache recording card and a protective recorder, wherein the master control board is connected with the digital board, the analogue board and the vibration board through a peripheral component interconnect (PCI) bus, is connected with the cache recording card through a serial advanced technology attachment (SATA) bus, and is connected with the protective recorder through an Ethernet bus. According to the system, a plurality of signals can be acquired, and the master control board is used for storing acquired data into the integrated cache recording card, so that acquisition and recording functions are realized by one piece of equipment; and maintenance data, status data and flight parameter data are synchronously acquired on an acquirer, and functions of data synchronization and important data filtration, forwarding and distribution to a flight parameter recorder for storage during ground playback analysis are realized in a time scale information packing and addition way. The aeronautic health control system can be widely applied to an automatic control system.
Owner:GUANGZHOU HANGXIN AVIATION TECH CO LTD

Method for analyzing urine exosome miRNA

PendingCN106399510AClarify the onsetElucidate the pathogenic mechanismMicrobiological testing/measurementCDNA libraryTotal rna
The invention provides a method for analyzing urine exosome miRNA, comprising: collecting a urine sample, extracting exosomes and their total RNA, establishing a cDNA library, performing Illumina sequencing, and processing and annotating the sequencing results to obtain expression information of sample miRNA expression quantity; urine sample exosome miRNA is analyzed by high-throughput sequencing technology to acquire expression information of miRNA; a database for IgA nephrotic patient and a healthy control patient is established, differentially expressed miRNA is deeply studied through target gene function prediction, the deep study on the differentially expressed miRNA helps further illustrate the pathogenesis of IgA nephropathy, and novel method and theoretical basis is provided for the diagnosis of IgA nephropathy. The method is reasonable and feasible in design, a noninvasive precise differential expression miRNA method can be effectively established, and novel ideas are provided for clinical diagnosis and treatment.
Owner:THE SECOND AFFILIATED HOSPITAL TO NANCHANG UNIV

Liver disease markers

New markers for diseased liver conditions have been identified. A combination of protein C (PROC) and retinol binding protein 4 (RBP4) in blood are biomarkers to distinguish patients at different stages of hepatic fibrosis due, for example, to chronic infection with hepatitis C virus (HCV). Also, alpha-1-B glycoprotein (A1BG), complement factor H (CFH) and insulin-like growth factor binding protein acid labile subunit (IGFALS) distinguish subjects with chronic or acute liver conditions such as hepatitis infection or liver fibrosis from healthy controls.
Owner:INSTITUTE FOR SYSTEMS BIOLOGY

Peripheral white blood cell miRNA markers associated with onset of human preeclampsia and application of miRNA markers

The invention belongs to the field of genetic engineering and clinical medicine. The invention aims to provide peripheral white blood cell miRNA markers associated with the onset of human preeclampsia. The invention also aims to provide an application of the miRNA markers. The miRNA markers can be many of has-miR-15a-3p, has-miR-31-3p, has-miR-451a and has-miR-122-5p. The peripheral white blood cell miRNA markers include has-miR-15a-3p, has-miR-31-3p, has-miR-451a and has-miR-122-5p. The peripheral white blood cell miRNA marker is applied to preparation of reagent for diagnosis or monitoring of human preeclampsia. The reagent is capable of determining the expression of the peripheral white blood cell microRNA marker in peripheral white blood cell. According to the invention, verifications are carried out on samples in line with preeclampsia and samples of a healthy control population to prove that the expressions of the markers are significantly different and the markers have stability and thus the results demonstrate that the markers have specificity and can be used as markers.
Owner:SHANXI MEDICAL UNIV

Mental disorder biomarker and application thereof

ActiveCN105543369AMonitoring the Effects of InterventionsMaster recoveryNervous disorderMicrobiological testing/measurementFecesGut flora
The invention discloses a mental disorder biomarker and application thereof. Microorganism gene chip hybridization research is conducted on intestinal flora microbial genomes in fecal samples of a mental disorder group and fecal samples of a healthy control group to describe characteristics of fecal microflorae and functional genes. By means of difference testing, discriminant analysis and machine learning, fifteen functional genes are recognized finally and can serve as biomarkers to highly accurately distinguish the mental disorder group. The biomarker is selected from at least ten genes in the fifteen functional genes. The fifteen functional genes have obvious differences in mental disorder people and the healthy people. The invention further discloses a drug which is capable of changing the number or expression of genes and is used for treating mental disorder, a method for producing or screening the drug for treating mental disorder and a kit for detecting mental disorder.
Owner:金锋 +1

Serological marker for detecting pancreatic cancer and a method for using the serological marker

UL16 binding protein 2 (ULBP2) is a protein overexpressed in pancreatic cancer tissues, and the ULBP2 levels are significantly higher in pancreatic cancer patients than those in healthy controls. This invention provides a method to detect pancreatic cancer using ULBP2 as a serological marker. The combination of ULBP2 and CA19-9 promotes the efficacy of pancreatic cancer detection. When measuring the blood ULBP2 levels in patients with other cancer types, including colorectal carcinoma, nasopharyngeal carcinoma and gastric cancer illustrates the blood ULBP2 levels are higher in patients with pancreatic cancer than other cancer types.
Owner:CHANG GUNG UNIVERSITY

DNA (Deoxyribonucleic Acid) methylation indicator for early diagnosis of cancers and hazard degree assessment and application thereof

The invention relates to a method for cancer diagnosis and / or cancer risk hazard degree assessment in subjects. The method comprises the following steps: a) determining DNA methylation states of samples from the subjects and samples from a healthy control group on at least one DNA methylation site; b) comparing the DNA methylation states of the samples from the subjects at the DNA methylation site with the DNA methylation states of the samples from the healthy control group at the corresponding DNA methylation site; and if the methylation states of the samples from the subjects and the samples from the healthy control group have remarkable difference, showing that the subjects have cancers or have cancer risks. The invention further provides a kit for the method provided by the invention.
Owner:TIANJIN MEDICAL UNIV CANCER INST & HOSPITAL

CircRNA marker used for breast cancer diagnosis and application of marker

The invention relates to a circRNA marker used for breast cancer diagnosis and an application of the circRNA marker. Compared with healthy control groups, it is found that expression of 3 kinds of circRNA (hsa_circ_0000745, hsa_circ_0001531 and hsa_circ_0001640) in whole blood of breast cancer is up-regulated. ROC curve analysis displays that the marker can better distinguish breast cancer patients and healthy people, and the 3 kinds of circRNA have the AUCs (area under curve) of 0.7998, 0.8253 and 0.7161 respectively, the sensitivity of 48.53%, 92.65% and 73.53% respectively and the specificity of 100%, 69.23% and 69.23% respectively.
Owner:SHANDONG UNIV QILU HOSPITAL

Method for recognizing spatial difference by utilizing complex number fMRI (functional magnetic resonance imaging) space source phase

The invention relates to a method for recognizing a spatial difference by utilizing a complex number fMRI (functional magnetic resonance imaging) space source phase, belonging to the technical field of biomedical signal processing. The method comprises the following steps of carrying out spatial ICA (independent component analysis) separation on complex number fMRI data, choosing an interesting ingredient, then performing phase correction and noise elimination to obtain the spatial source phase of the interesting ingredient, and finally, calculating through a variance homogeneity analysis anda variance difference coefficient so as to recognize the differences of SZs and HCs in the spatial source phase. Compared with widely applied amplitude data, the method utilizes the spatial source phase to recognize the spatial difference between a schizophrenia patient group and a healthy control group, and can display higher flexibility and reliability. For example, specific to complex number fMRI data of 82 testees in a quiescent condition, the spatial source phase is used for extracting differential voxel, which is increased by more than 122.95% in DMN, on the premise of not using FDR correction, and the differential voxel, which is extracted from the spatial source phase and can pass the FDR correction, is 69% more than the amplitude.
Owner:DALIAN UNIV OF TECH

Diagnosis kit for Parkinson's disease, and application of diagnosis kit

The invention relates to a diagnosis kit for Parkinson's disease, and application of the diagnosis kit. According to the diagnosis kit, single-blind detection is carried out on the expression levels of miR-105-5p, miR-21-5p, miR-29a-5p and miR-30e-5p in plasma of 263 patients with the Parkinson's disease and a healthy control group of 242 hpersons having matched ages and sexes, and the four miRNAs are found to be significantly different in the plasma of patients with the Parkinson's disease and the plasma of healthy people, so that the four miRNAs are suggested to used as a molecular marker for preparing the kit for the Parkinson's disease, or to be used for preparing medicines for treating the Parkinson's disease. After the kit is used, the medication compliance has remarkable influence on the miR-21-5p, so that the kit can be used for screening the medicines for treating the Parkinson's disease.
Owner:乐卫东
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products